Literature DB >> 22980050

Glucocorticoids as mediators of developmental programming effects.

Batbayar Khulan1, Amanda J Drake.   

Abstract

Epidemiological evidence suggests that exposure to an adverse environment in early life is associated with an increased risk of cardio-metabolic and behavioral disorders in adulthood, a phenomenon termed 'early life programming'. One major hypothesis for early life programming is fetal glucocorticoid overexposure. In animal studies, prenatal glucocorticoid excess as a consequence of maternal stress or through exogenous administration to the mother or fetus is associated with programming effects on cardiovascular and metabolic systems and on the brain. These effects can be transmitted to subsequent generations. Studies in humans provide some evidence that prenatal glucocorticoid exposure may exert similar programming effects on glucose/insulin homeostasis, blood pressure and neurodevelopment. The mechanisms by which glucocorticoids mediate these effects are unclear but may include a role for epigenetic modifications. This review discusses the evidence for glucocorticoid programming in animal models and in humans.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22980050     DOI: 10.1016/j.beem.2012.03.007

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  32 in total

Review 1.  Role of nuclear receptors in blastocyst implantation.

Authors:  Y M Vasquez; F J DeMayo
Journal:  Semin Cell Dev Biol       Date:  2013-08-28       Impact factor: 7.727

Review 2.  Glucocorticoid receptor signaling in health and disease.

Authors:  Mahita Kadmiel; John A Cidlowski
Journal:  Trends Pharmacol Sci       Date:  2013-08-14       Impact factor: 14.819

3.  Prenatal arsenic exposure alters the programming of the glucocorticoid signaling system during embryonic development.

Authors:  Katharine E Caldwell; Matthew T Labrecque; Benjamin R Solomon; Abdulmehdi Ali; Andrea M Allan
Journal:  Neurotoxicol Teratol       Date:  2014-11-21       Impact factor: 3.763

4.  Effect of prenatal steroid treatment on the developing immune system.

Authors:  Ines Diepenbruck; Chressen C Much; Aniko Krumbholz; Manuela Kolster; René Thieme; Detlef Thieme; Silke Diepenbruck; M Emilia Solano; Petra C Arck; Eva Tolosa
Journal:  J Mol Med (Berl)       Date:  2013-07-14       Impact factor: 4.599

5.  Oxytocin trajectories and social engagement in extremely premature infants during NICU hospitalization.

Authors:  Ashley Weber; Tondi M Harrison; Deborah Steward; Loraine Sinnott; Abigail Shoben
Journal:  Infant Behav Dev       Date:  2017-05-25

6.  Experts' Opinion on the Prenatal Therapy of Congenital Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency - Guideline of DGKED in cooperation with DGGG (S1-Level, AWMF Registry No. 174/013, July 2015).

Authors:  H G Dörr; G Binder; N Reisch; U Gembruch; P G Oppelt; P Wieacker; J Kratzsch
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-12       Impact factor: 2.915

7.  Foetal exposure to Panax ginseng extract reverts the effects of prenatal dexamethasone in the synthesis of testosterone by Leydig cells of the adult rat.

Authors:  Maria I Wanderley; Karina L A Saraiva; Juliany S B César Vieira; Christina A Peixoto; Daniel P Udrisar
Journal:  Int J Exp Pathol       Date:  2013-06       Impact factor: 1.925

Review 8.  Effects of antenatal glucocorticoids on the developing brain.

Authors:  Ross Carson; A Paula Monaghan-Nichols; Donald B DeFranco; Anthony C Rudine
Journal:  Steroids       Date:  2016-06-23       Impact factor: 2.668

Review 9.  New insight on the molecular aspects of glucocorticoid effects in nervous system development.

Authors:  R Maggi; D Dondi; M Piccolella; L A Casulari; L Martini
Journal:  J Endocrinol Invest       Date:  2013-06-10       Impact factor: 4.256

Review 10.  A role for glucocorticoids in stress-impaired reproduction: beyond the hypothalamus and pituitary.

Authors:  Shannon Whirledge; John A Cidlowski
Journal:  Endocrinology       Date:  2013-09-24       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.